Efficacy and safety of house dust mite cluster immunotherapy in the treatment of allergic rhinitis and asthma: a multicenter prospective single-arm interventional study
Objective To investigate the efficacy and safety of 4-week cluster immunotherapy with house dust mite extracts in patients allergic to house dust mites. Methods From August 2022 to May 2024, 80 patients with house dust mite-induced allergic rhinitis, complicated with or without asthma, were recruite...
Saved in:
| Main Author: | SHANG Tengze, LI Lisha, WANG Qing, DENG Baiyu, ZHANG Xiaoli, HUANG Yan, JIN Xiuhong, MENG Wenxia, YAO Hui, GUAN Kai |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of New Medicine
2024-10-01
|
| Series: | Xin yixue |
| Subjects: | |
| Online Access: | https://www.xinyixue.cn/fileup/0253-9802/PDF/1731477169080-2037111632.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of the COVID-19 pandemic and lockdown measures on clinical visits and subjective symptoms in childhood allergic rhinitis induced by house dust mites in Shanghai
by: Wenjun He, et al.
Published: (2024-11-01) -
Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trialResearch in context
by: Antje Schuster, et al.
Published: (2025-01-01) -
Evaluating allergic sensitization in pediatric patients: A cross-sectional multicentric analysis
by: V. Y. Jayakrishnan, et al.
Published: (2024-12-01) -
Clinical Trial With a Depigmented, Polymerized Mite Mixture Extract at Maximum Concentrations
by: Carmen Vidal, et al.
Published: (2024-12-01) -
Is immunotherapy protective against steroid intake in patients with polysensitized allergic rhinitis and/or asthma?
by: Feridun Gürlek
Published: (2024-11-01)